PRODUCTS
SERVICES
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
2.18
1 yrs 0 m
1%
1,302.67 Crs
1% on or before 30D, Nil after 30D
Large Growth
7.26
SIP 100 & Lumpsum 100
BSE HEALTH CARE - TRI
Nikhil Mathur
Investors understand that their principal will be at very high risk